The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination
Open accessAbstract
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide and is associated with high case fatality rates and serious life-long complications among survivors. Twelve serogroups are recognised, of which six (A, B, C, W, X and Y) are responsible for nearly all cases of invasive meningococcal disease (IMD). The incidence of IMD and responsible serogroups vary widely both geographically and over time. For the first time, effective vaccines against all these serogroups are available or nearing licensure. Over the past two decades, IMD incidence has been declining across most parts of the world through a combination of successful meningococcal immunisation programmes and secular trends. The introduction of meningococcal C conjugate vaccines in the early 2000s was associated with rapid declines in meningococcal C disease, whilst implementation of a meningococcal A conjugate vaccine across the African meningitis belt led to near-elimination of meningococcal A disease. Consequently, other serogroups have become more important causes of IMD. In particular, the emergence of a hypervirulent meningococcal group W clone has led many countries to shift from monovalent meningococcal C to quadrivalent ACWY conjugate vaccines in their national immunisation programmes. Additionally, the recent licensure of two protein-based, broad-spectrum meningococcal B vaccines finally provides protection against the most common group responsible for childhood IMD across Europe and Australia. This review describes global IMD epidemiology across each continent and trends over time, the serogroups responsible for IMD, the impact of meningococcal immunisation programmes and future needs to eliminate this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31449-6 · Cited by 457
Global epidemiology of invasive meningococcal disease
Jafri, R. Z., Ali, A., Messonnier, N. E., Tevi-Benissan, C., Durrheim, D., Eskola, J., Fermon, F., Klugman, K. P., Ramsay, M., Sow, S., et al. (2013) · Population Health Metrics · doi:10.1186/1478-7954-11-17 · Cited by 372
Self-citationTappero, J. W., Lagos, R., Maldonado Ballesteros, A., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L. L., Carlone, G. M., Høiby, E. A., Holst, J., et al. (1999) · JAMA · doi:10.1001/jama.281.16.1520 · Cited by 369
Cohn, A. C., MacNeil, J. R., Harrison, L. H., Hatcher, C., Theodore, J., Schmidt, M., Pondo, T., Arnold, K. E., Baumbach, J., Bennett, N., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649209 · Cited by 345
Self-citationParikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31921-3 · Cited by 275
Self-citationBorrow, R., Alarcón, P., Carlos, J., Caugant, D. A., Christensen, H., Debbag, R., De Wals, P., Echániz-Aviles, G., Findlow, J., Head, C., et al. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1258308 · Cited by 269
Self-citationAdvances in the Development of Vaccines against Neisseria meningitidis
Tan, L. K. K., Carlone, G. M., & Borrow, R. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906357 · Cited by 233
Self-citationHolst, J., Oster, P., Arnold, R., Tatley, M., Næss, L., Aaberge, I., Galloway, Y., McNicholas, A., O'Hallahan, J., Rosenqvist, E., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24129 · Cited by 225
Lucidarme, J., Hill, D. M. C., Bratcher, H. B., Gray, S. J., du Plessis, M., Tsang, R. S. W., Vazquez, J. A., Taha, M.-K., Ceyhan, M., Efron, A. M., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.07.007 · Cited by 225
Self-citationCampbell, H., Andrews, N., Borrow, R., Trotter, C., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213
Self-citation
Research works printed but not linked: 62
- Dastouri, 2014, Complications of serogroup B meningococcal disease in survivors: a review, Infect Disord Drug Targets, 14, 205, 10.2174/1871526515999150320155614 · doi:10.2174/1871526515999150320155614
- Beebeejaun, 2020, Invasive meningococcal disease: timing and cause of death in England, J Infect doi, 2008
- 2019, Invasive meningococcal disease: Annual Epidemiological Report for 2017, ECfDPaC
- Campbell, 2019, Invasive meningococcal disease as a cause of sudden and unexpected death in a teenager: The public health importance of confirming the diagnosis, J Infect, 78, 323, 10.1016/j.jinf.2018.11.004 · doi:10.1016/j.jinf.2018.11.004
- Beresford, 2017, Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines, Vaccine35, 3598, 10.1016/j.vaccine.2017.03.066 · doi:10.1016/j.vaccine.2017.03.066
- 2019, Meningococcal Disease
- Krone, 2019, Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017, Euro Surveil, l24
- 2019, Invasive Meningococcal Disease in Ireland, 2018, on HSE HSE
- 2019, Meningococcal B
- Knol, 2017, Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study, Lancet Public Health, 2, e473, 10.1016/S2468-2667(17)30157-3 · doi:10.1016/s2468-2667(17)30157-3
- Hong, 2018, Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France, J Infect, 76, 149, 10.1016/j.jinf.2017.10.015 · doi:10.1016/j.jinf.2017.10.015
- Soeters, 2019, University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018, Emerg Infect Dis, 25, 434, 10.3201/eid2503.181574 · doi:10.3201/eid2503.181574
- Fiorito, 2017, Rapid response to a college outbreak of meningococcal serogroup B disease: Nation's first widespread use of bivalent rLP2086 vaccine, J Am Coll Health, 65, 294, 10.1080/07448481.2017.1285772 · doi:10.1080/07448481.2017.1285772
- Law, 2006, Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19), J Clin Microbiol, 44, 2743, 10.1128/JCM.00601-06 · doi:10.1128/jcm.00601-06
- Bettinger JAS M, Morris S, Le Saux N, Top K, Vaudry W, Halperin S, Tsang R, 2018. Poster P59. The effect of quadrivalent vaccination programs in Canada; September 23-28, 2018., abstr International Pathogenic Neisseria Conference (IPNC), Asilomar, USA.
- Langley, 2016, Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study, Vaccine34, 4046, 10.1016/j.vaccine.2016.06.025 · doi:10.1016/j.vaccine.2016.06.025
- Bettinger, 2013, The disease burden of invasive meningococcal serogroup B disease in Canada, Pediatr Infect Dis J, 32, e20, 10.1097/INF.0b013e3182706b89 · doi:10.1097/inf.0b013e3182706b89
- Safadi, 2015, The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations, Vaccine33, 6529, 10.1016/j.vaccine.2015.10.055 · doi:10.1016/j.vaccine.2015.10.055
- 2018, Regional Inform from SIREVA II, 2015. Data by country and by age Group on characteristics of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis isolates in invasive bacterial infections, on Organización Panamericana de la Salud
- 2019, Notifiable Diseases Information System – Sinan
- Bakira, 2018, Update on meningococcal disease and its prevention, Rev Hosp Niños, 60, 42
- 2019, Bacterial meningitis and meningococcal disease
- Chacon-Cruz, 2019, Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005-2018, Ther Adv Infect Dis, 6
- Tiffay, 2015, The Evolution of the Meningitis Vaccine Project, Clin Infect Dis 61 Suppl 5, S396, 10.1093/cid/civ594 · doi:10.1093/cid/civ594
- Nnadi, 2017, Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017, MMWR Morb Mortal Wkly Rep, 66, 1352, 10.15585/mmwr.mm6649a3 · doi:10.15585/mmwr.mm6649a3
- 2016, WHO guidelines for the treatment of Neisseria gonorrhoea
- Shao, 2006, Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China, Lancet, 367, 419, 10.1016/S0140-6736(06)68141-5 · doi:10.1016/s0140-6736(06)68141-5
- Junhong, 2015, Epidemiological Characteristics of Meningococcal Meningitis and Switching Trend of Serogroups of Neisseria meningitidis in China, Chin J Vaccine Immun, 21, 2006
- Juhong, 2019, Analysis of epidemic characteristics for meningococcal meningitis in China during 2015-2017, Chin J Prev Med, 53, 159
- Zhang, 2016, Burden of Neisseria meningitidis infections in China: a systematic review and meta-analysis, J Glob Health, 6, 10.7189/jogh.06.020409 · doi:10.7189/jogh.06.020409
- Zhou, 2013, Spread of Neisseria meningitidis serogroup W clone, China, Emerg Infect Dis, 19, 1496, 10.3201/eid1909.130160 · doi:10.3201/eid1909.130160
- Hu, 2014, Neisseria meningitidis serogroup W135 sequence type 11, Anhui Province, China, 2011-2013, Emerg Infect Dis, 20, 1236, 10.3201/eid2007.131138 · doi:10.3201/eid2007.131138
- Zhang, 2008, Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005, Clin Microbiol Infect, 14, 555, 10.1111/j.1469-0691.2008.01977.x · doi:10.1111/j.1469-0691.2008.01977.x
- Zhou, 2015, Clonal characteristics of invasive Neisseria meningitidis following initiation of an A + C vaccination program in China, J Infect, 70, 2005, 10.1016/j.jinf.2014.07.022 · doi:10.1016/j.jinf.2014.07.022
- Zhu, 2015, Sequence Type 4821 Clonal Complex Serogroup B Neisseria meningitidis in China, 1978-2013, Emerg Infect Dis, 21, 925, 10.3201/eid2106.140687 · doi:10.3201/eid2106.140687
- Shao, 2010, Neisseria meningitidis serogroup W135, China, Emerg Infect Dis, 16, 348, 10.3201/eid1602.090901 · doi:10.3201/eid1602.090901
- Zhu, 2020, Comparative genomic analyses of Chinese serogroup W ST-11 complex Neisseria meningitidis isolates, J Infect, 80, 54, 10.1016/j.jinf.2019.08.019 · doi:10.1016/j.jinf.2019.08.019
- Zhu, 2019, Comparative genomic analyses of Chinese serogroup W ST-11 complex Neisseria meningitidis isolates, J Infect doi
- Chen, 2008, A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China, Chin Med J (Engl), 121, 664, 10.1097/00029330-200804010-00017 · DOI
- Pan, 2014, The case of a new sequence type 7 serogroup X Neisseria meningitidis infection in China: may capsular switching change serogroup profile?, Int J Infect Dis, 29, 62, 10.1016/j.ijid.2014.07.022 · doi:10.1016/j.ijid.2014.07.022
- Zhu, 2017, Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A, Infect Immun, 85, 10.1128/IAI.01019-16 · doi:10.1128/iai.01019-16
- Li, 2019, The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China, J Infect doi, 10.1016/j.jinf.2019.07.001 · doi:10.1016/j.jinf.2019.07.001
- Fukusumi, 2016, National surveillance for meningococcal disease in Japan, Vaccine34, 1999
- John, 2013, An overview of meningococcal disease in India: knowledge gaps and potential solutions, Vaccine31, 2731, 10.1016/j.vaccine.2013.04.003 · doi:10.1016/j.vaccine.2013.04.003
- Sinclair, 2010, The epidemiology of meningococcal disease in India, Trop Med Int Health, 15, 1421, 10.1111/j.1365-3156.2010.02660.x · doi:10.1111/j.1365-3156.2010.02660.x
- Taj, 2016, Detection of meningococcal meningitis in cerebrospinal fluid of patients with neurological disorders in government hospitals of Karachi, J Pak Med Assoc, 66, 1418
- Hossain, 2009, Increasing isolations of Neisseria meningitides serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999-2006, Am J Trop Med Hyg, 80, 615, 10.4269/ajtmh.2009.80.615 · doi:10.4269/ajtmh.2009.80.615
- 2019, Australia's notifiable diseases status, 2015: Annual report of the National Notifiable Diseases Surveillance System (NNDSS), Commun Dis Intell, 43, 1
- 2019, Meningococcal Disease
- 2019, Disease notification rates, Australia, 1991 to 2018 and year-to-date notifications for 2019, on Australian Government Department of Health
- 2018, Invasive Meningococcal Disease National Surveillance Report - With a focus on MenW - 31 March 2018, on Australian Government Department of Health
- Lahra, 2013, Australian Meningococcal Surveillance Programme annual report, 2012, Commun Dis Intell Q Rep, 37, E224, 10.33321/cdi.2013.37.34 · doi:10.33321/cdi.2013.37.34
- Lahra, 2014, Australian Meningococcal Surveillance Programme annual report, 2013, Commun Dis Intell Q Rep, 38, E301, 10.33321/cdi.2014.38.50 · DOI
- Lahra, 2016, Australian Meningococcal Surveillance Programme annual report, 2014, Commun Dis Intell Q Rep, 40, E221, 10.33321/cdi.2016.40.17 · doi:10.33321/cdi.2016.40.17
- Lahra, 2016, Australian Meningococcal Surveillance Programme annual report, 2015, Commun Dis Intell Q Rep, 40, E503, 10.33321/cdi.2016.40.57 · doi:10.33321/cdi.2016.40.57
- Martin, 2016, Rise in invasive serogroup W meningococcal disease in Australia 2013-2015, Commun Dis Intell Q Rep, 40, E454, 10.33321/cdi.2016.40.50 · doi:10.33321/cdi.2016.40.50
- 2019, NOVEMBER 2019 PBAC MEETING – POSITIVE RECOMMENDATIONS
- 2019, Meningococcal disease
- O'Hallahan, 2004, The strategy to control New Zealand's epidemic of group B meningococcal disease, Pediatr Infect Dis J, 23
- Safadi, 2017, Knowing the scope of meningococcal disease in Latin America, Rev Panam Salud Publica, 41, e118
- Tzeng, 2017, Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen, Proc Natl Acad Sci U S A, 114, 4237, 10.1073/pnas.1620971114 · doi:10.1073/pnas.1620971114
- Deghmane, 2017, Emergence of meningococci with reduced susceptibility to third-generation cephalosporins, J Antimicrob Chemother, 72, 95, 10.1093/jac/dkw400 · doi:10.1093/jac/dkw400
Cited by
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Metadata
- Authors
- Parikh, S. R., Campbell, H., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinon-Torres, F., Safadi, M. A., Shao, Z., Zhu, B., von Gottberg, A., Borrow, R., Ramsay, M. E., & Ladhani, S. N.
- Venue
- Journal of Infection
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 81
- Issue
- 4
- Pages
- 483-498
- ISSN
- 0163-4453 (ISSN-L)
- OpenAlex
- W3033885385
- Cited by
- 274
- References
- 99
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. https://app.cochat.ai/papers/10.1016/j.jinf.2020.05.079
- The paper
- Parikh, S. R., Campbell, H., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinon-Torres, F., Safadi, M. A., Shao, Z., Zhu, B., von Gottberg, A., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2020). The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Journal of Infection. https://doi.org/10.1016/j.jinf.2020.05.079
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.